News

When healthcare met politics with time running out: 3 new developments

The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability.

old woman or doctor shaking hands with patient

Women are more likely to have severe aortic stenosis missed on echocardiography results

Three out of four TTEs are being ordered by clinicians who are not cardiologists. Could this be having a negative impact on patient care?

The Medtronic Liberant thrombectomy system.

New Medtronic thrombectomy system used commercially for first time

The new device uses an advanced algorithm to regulate aspiration and conserve blood. Ajit Rao, MD, a vascular surgeon with The Mount Sinai Hospital, performed the historic procedure.

Milestone Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for etripamil, a new nasal spray for adult patients with paroxysmal supraventricular tachycardia (PSVT).

FDA approves new nasal spray for patients with abnormal heart rhythms

Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.

breast cancer mammography screening mammogram scheduling

American College of Radiology criticizes prominent study pushing for new approach to breast cancer screening

Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.

statue justice legal verdict malpractice case lawsuit scale

Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors

Alleged transgressions took place between February and August, including the FDA rejecting Telix’s application for a new brain cancer imaging agent.

Dual-energy CT systems allow for significant reduction in contrast dose

DECT systems allow for a contrast dose reduction of up to 25% during computed tomography pulmonary angiography exams.

New recalls announced for troubled heart devices—FDA previously urged customers to seek alternatives

These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

Lawsuit claims clinic used AI to record patient conversations without consent

According to attorneys representing a potential class action of plaintiffs, Sharp HealthCare was not forthcoming about its use of a tool for automatic note-taking. The technology allegedly captures everything said in an exam room, including sensitive details on diagnoses, and sends it to an offsite server.

White House executive order aims to curb ‘excessive’ state regulation of AI

President Donald Trump wants to establish an AI Litigation Task Force to challenge any AI laws that may “harm innovation.”

Around the web

Health Exec